Literature DB >> 18061105

The natural history and complications of eosinophilic esophagitis.

Alex Straumann1.   

Abstract

Eosinophilic esophagitis is a chronic disease limited to the esophagus and has a persistent or spontaneously fluctuating course. So far it does not seem to limit life expectancy, but it often substantially impairs the quality of life. To date, there has been no association with malignant conditions, but there is concern that the chronic, uncontrolled inflammation will evoke irreversible structural alterations of the esophagus, leading to tissue fibrosis, stricture formation, and impaired function. This esophageal remodeling may result in several disease-inherent and procedure-related complications.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18061105     DOI: 10.1016/j.giec.2007.09.009

Source DB:  PubMed          Journal:  Gastrointest Endosc Clin N Am        ISSN: 1052-5157


  25 in total

1.  An evolving case of concurrent eosinophilic esophagitis and eosinophilic gastroenteritis.

Authors:  Minou Le-Carlson; George Triadafilopoulos; Reteesh K Pai; John A Kerner
Journal:  Dig Dis Sci       Date:  2012-02-04       Impact factor: 3.199

Review 2.  Relationships between eosinophilic inflammation, tissue remodeling, and fibrosis in eosinophilic esophagitis.

Authors:  Seema S Aceves; Steven J Ackerman
Journal:  Immunol Allergy Clin North Am       Date:  2009-02       Impact factor: 3.479

3.  Eosinophilic oesophagitis: a clinical update.

Authors:  Jamal O Hayat; Kalliopi Alexandropoulou; Andrew P Poullis; Jin-Yong Kang
Journal:  Br J Gen Pract       Date:  2012-09       Impact factor: 5.386

4.  Montelukast was inefficient in maintaining steroid-induced remission in adult eosinophilic esophagitis.

Authors:  Alfredo J Lucendo; Livia C De Rezende; Susana Jiménez-Contreras; Jose Luis Yagüe-Compadre; Jesús González-Cervera; Teresa Mota-Huertas; Danila Guagnozzi; Teresa Angueira; Sonia González-Castillo; Angel Arias
Journal:  Dig Dis Sci       Date:  2011-06-15       Impact factor: 3.199

5.  TGF-β1-induced phospholamban expression alters esophageal smooth muscle cell contraction in patients with eosinophilic esophagitis.

Authors:  Lisa Y Beppu; Arjun A Anilkumar; Robert O Newbury; Ranjan Dohil; David H Broide; Seema S Aceves
Journal:  J Allergy Clin Immunol       Date:  2014-05-13       Impact factor: 10.793

6.  Variation in prevalence, diagnostic criteria, and initial management options for eosinophilic gastrointestinal diseases in the United States.

Authors:  Jonathan M Spergel; Wendy M Book; Elizabeth Mays; Lihal Song; Samir S Shah; Nicholas J Talley; Peter A Bonis
Journal:  J Pediatr Gastroenterol Nutr       Date:  2011-03       Impact factor: 2.839

7.  Low Prevalence of Biopsy-Proven Eosinophilic Esophagitis in Patients with Esophageal Food Impaction in Mexican Population.

Authors:  Diego García-Compeán; José A González-González; José J Duran-Castro; Gilberto Herrera-Quiñones; Omar D Borjas-Almaguer; Héctor J Maldonado-Garza
Journal:  Dig Dis Sci       Date:  2018-03-29       Impact factor: 3.199

8.  Eosinophilic gastrointestinal diseases--clinically diverse and histopathologically confounding.

Authors:  Seema Aceves; Ikuo Hirano; Glenn T Furuta; Margaret H Collins
Journal:  Semin Immunopathol       Date:  2012-07-29       Impact factor: 9.623

Review 9.  Eosinophilic esophagitis: the newest esophageal inflammatory disease.

Authors:  Dan Atkins; Robert Kramer; Kelley Capocelli; Mark Lovell; Glenn T Furuta
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-05       Impact factor: 46.802

10.  Contribution of endoscopy in the management of eosinophilic esophagitis.

Authors:  Cristina Targa Ferreira; Helena As Goldani
Journal:  World J Gastrointest Endosc       Date:  2012-08-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.